SCHEMBL27879617

SCHEMBL27879617

CC(C)(C)OC1CC(NC=O)N(C(=O)CC2CC2)C1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28054733 0.81 — —
SCHEMBL27896387 0.79 TSHR (0.40) —
SCHEMBL27896445 0.76 ATM (0.30) —
SCHEMBL27896421 0.76 KMT2A (0.42) —
SCHEMBL27896436 0.75 LOXL2 (0.34) —
SCHEMBL27879647 0.75 VHL (0.49) —
SCHEMBL27896413 0.75 CYP1A2 (0.39) —
SCHEMBL28054871 0.74 PIK3CD (0.39) —
SCHEMBL27879651 0.68 — —
SCHEMBL27879615 0.67 PREP (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102791693-B Hepatitis c virus inhibitors BRISTOL-MYERS SQUIBB CO. (US) 2016-04-13 — — CN claimed
CN-102791693-A Hepatitis c virus inhibitors BRISTOL MYERS SQUIBB CO 2012-11-21 — — CN claimed
Send feedback